TCG Expands Its US Market Entry Services to Japan
TCG Partner Nat Bowditch will be participating in the Medical Japan Conference in Tokyo, October 23-25, 2019.
For more than twenty years, TCG has assisted medical device companies in Europe and Asia to successfully enter and grow in the United States. The TCG partners are highly experienced, senior medical device industry executives who have run large and small companies and divisions in orthopedics, cardiology, ophthalmology, diagnostic imaging, wound care, oncology, gastroenterology, urology, regenerative medicine, rehabilitation medicine, dentistry, respiratory care, neurology, gynecology, ENT and many other medical fields. TCG can help your company:
- Determine the market size for a product
- Identify the necessary FDA pathway
- Evaluate the reimbursement situation and implications for pricing
- Introduce the company to key opinion leaders at leading academic medical centers
- Identify distribution or licensing partners
The United States medical device market is the largest in the world. With attractive product pricing, generally higher than in Europe and most countries in Asia, the US market offers a significant opportunity for rapid, profitable growth for innovative Medtech companies. But knowing where the biggest opportunities lie, how best to access customers, and navigating complex regulatory and reimbursement pathways can be unclear and challenging. The Technology Commercialization Group (TCG) can help your company identify opportunity, overcome challenges and successfully enter and grow in the US.
To learn more about how TCG can help your company grow, call919-941-0700 or email nat.bowditch@tcgmedtech.com.
Visit our website at www.tcgmedtech.com